FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066830 [Registered on: 06/05/2024] Trial Registered Prospectively
Last Modified On: 03/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing the efficacy of cyanoacrylate glue with standard treatment modalities in anal fistula  
Scientific Title of Study   Efficacy of cyanoacrylate glue versus fistulotomy in the management of simple low anal fistula in tertiary care hospital - A Randomised Controlled study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kumaravel 
Designation  Post graduate student 
Affiliation  Pondicherry Institute of Medical Sciences  
Address  Department of general surgery Pondicherry institute of medical sciences Ganapathichettikulam Kalapet

Pondicherry
PONDICHERRY
605014
India 
Phone  9790051660  
Fax    
Email  drkumaravel26@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Peter Manoharan chellappa 
Designation  Professor 
Affiliation  Pondicherry Institute of Medical Sciences  
Address  Department of general surgery 1st floor OPD extension block Pondicherry Institute of Medical Sciences Ganapathichettikulam Kalapet

Pondicherry
PONDICHERRY
605014
India 
Phone  9447591100  
Fax    
Email  peternirmala@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Peter manoharan chellapa 
Designation  Professor 
Affiliation  Pondicherry Institute of Medical Sciences  
Address  Department of general surgery 1st floor OPD extension block Pondicherry Institute of Medical Sciences Ganapathichettikulam Kalapet

Pondicherry
PONDICHERRY
605014
India 
Phone  9447591100  
Fax    
Email  peternirmala@yahoo.com  
 
Source of Monetary or Material Support  
Pondicherry Institute of Medical Sciences  
 
Primary Sponsor  
Name  Kumaravel  
Address  Room no 225 2nd floor PG boys hostel Annexe block Pondicherry Institute of Medical Sciences campus Ganapathichettikulam Kalapet Puducherry 605014 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kumaravel   Pondicherry Institute of Medical Sciences   Department of general surgery 1st floor OPD Extension building Ganapathichettikulam Kalapet
Pondicherry
PONDICHERRY 
9790051660

drkumaravel26@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PIMS INSTITUTE ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cyanoacrylate glue application   Patient will be given 1-3ml of cyanoacrylate glue (depending upon the length of fistula) via 8F infant feeding tube loaded in syringe into the fistula tract til internal opening is reached and glue will be injected gradually. Patient will be followed up after 24 hours of surgery, after 2 weeks and once a month for 2 months. The wound healing time will be assessed after 3 months of follow up period. The total duration of intervention is for 3 months  
Comparator Agent  Fistulotomy  Pateint will undergo surgical procedure such as lay open of the fistula tract as a complete transection between the fistula tract and anoderm. The tract will be taken out of the surrounding tissue and will be incised into the subcutaneous tissue. Patient will be followed up after 24 hours of surgery,after 2 weeks and once a month for 2 months.The wound healing time will be assessed after 3 months of follow up. The total duration of intervention is for 3 months. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Patient undergoing simple low anal fistula surgeries 
 
ExclusionCriteria 
Details  1)Complex and high anal fistula
2)Diabetes mellitus  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Duration of wound healing   24 hours,2 weeks,1 month,2 months, 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
1)Post operative pain
2)Duration of hospital stay
3)Maintenance of anal continence 
24 hours,2weeks,1month,2 months,3 months 
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   14/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="10"
Days="16" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drkumaravel26@gmail.com].

  6. For how long will this data be available start date provided 01-11-2026 and end date provided 31-10-2029?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   SUMMARY OF PROTOCOL

Objective: To compare the duration of wound healing between cyanoacrylate glue application and fistulotomy in patients with simple low anal fistula. The secondary outcome measured are Post operative pain, Duration of hospital stay, Maintenance of anal continence.
Materials and methods:
This Randomized control study design includes patients above 18 years of age with simple low anal fistula. Exclusion criteria are complex and high anal fistula and Diabetes mellitus. After Computer generated block randomization, two groups with 28 study participants in each group will be allocated. Group A will undergo fistulotomy. Group B will receive 1-3 ml of N-butyl cyanoacrylate glue in to the fistula tract. After 24 hours, patient will be discharged and will be followed up every 2 weeks for one month and monthly once for 2 months. 
Data will be collected in the predesigned case report form and following measuring tools will be used
1)Complete healing (epithelization) at 24 hours after surgery, at time of discharge,1st,2nd,3rd month 
2)Pain will be assessed before intervention and at 24 hours after surgery, at time of discharge,1st, 2nd,3rd month using Visual analog scale
3)Post operative incontinence to Gas/Liquids/solids at 24 hours, after surgery, at time of discharge, 1st, 2nd, 3rd month will be measured using The Wexner score
All the collected data will be entered in a Microsoft Excel sheet and will be analyzed using SPSS software and categorical data will be expressed in percentage or number and will be measured using Chi-square test. All numerical data will be expressed as mean and standard deviation and measured using independence t test. P value <0.05 will be considered as significant.
 
Close